
Keros Therapeutics, Inc.
Keros Therapeutics, Inc. (KROS)
WebsitePrice
Market cap
Next catalystExpected 2H 2026Rinvatercept — planned ALS development · Regulatory meetingSEC filing ↗
Cash
Chart & Events
Core Clinical
PreINDP1P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
PreINDP1P3FilingApproved